| ||
Orexigen soars in wake of FDA diet-drug approval MarketWatch BOSTON (MarketWatch) -- Shares of Orexigen Therapeutics (US:orex) soared for the second day on Thursday, buoyed by renewed hopes that the company's diet drug Contrave will eventually win approval by. See all stories on this topic » | ||
| ||
Steady diet of Lyric shows, other live entertainment key to downtown Stuart ... TCPalm Symbiosis defines the relationship between The Lyric Theatre and businesses that surround it in downtown Stuart. See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment